Atlas Trials

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

Clinical trial NCT01848730 · COMPLETED

Trial details

NCT number
NCT01848730
Sponsor
Convergence Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Post-herpetic Neuralgia
Start date
2013-04-01
Primary completion
2014-02-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.